SynthesisEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025
Multiparametric models for predicting major arrhythmic events in Brugada syndrome: a systematic review and critical appraisal.
Synthesis in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Long-term predictors of outcome in Brugada syndrome patients after implantable cardioverter-defibrillator implant.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Article
- Impact of Atrial Fibrillation on the Outcome of Patients with Brugada Syndrome: A Meta-Analysis.Journal of cardiovascular development and disease · 2025Review
- A heart job: predicting sudden cardiac arrest.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025Article
- Current perspectives on risk prediction and genetic basis of Brugada syndrome.Frontiers in cardiovascular medicine · 2025Review
- Brugada syndrome risk scores: what we've learned and what's next.Frontiers in cardiovascular medicine · 2025Review
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
aimsDespite several risk models to predict major arrhythmic events (MAE) in Brugada syndrome (BrS) having been developed, reproducibility and methodology remain a concern. Our aim was to assess the quality of model development and validation, and determine the discriminative performance of available models. METHODS AND
resultsElectronic databases (Medline, Embase, and Central) were searched through September/2024 for studies developing or validating multivariable prediction models for MAE in BrS. Methodological quality and risk of bias (RoB) were assessed using the Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS) checklist and the Prediction Model Risk of Bias Assessment (PROBAST) Tool. Pooled random-effects c-statistics were obtained for each model. A total of 16 studies, including 11 unique multivariable scores, were included. All models had domains classified as high RoB. Common sources of bias were inappropriate inclusion/exclusion criteria, predictor selection, low number of events and underreporting of performance measures. Pooled c-statistics among patients without previous MAE showed good performance for Brugada-Risk [AUC 0.81, 95% confidence interval (CI) 0.71-0.91; I2 64%; three studies], fair for PAT (AUC 0.79, 95% CI 0.45-1.12; I2 95%; two studies), Delise (AUC 0.77, 95% CI 0.72-0.81, I2 39%, three studies), and Sieira (AUC 0.73, 95% CI 0.64-0.82; I2 64%; five studies), and moderate for Shanghai (AUC 0.69, 95% CI 0.61-0,76; I2 13%; three studies).
conclusionCurrently available multiparametric models for prediction of MAE in BrS have important shortcomings in model development and inadequate evaluation. Further validation of current models in external cohorts is required before safe transition to clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.